Biological systems are inherently complex and targeting a single molecule or pathway rarely produces a large enough impact in the diseases process to be translated into maximal therapeutic efficacy. There is a pressing need to develop an efficient process to test the combination of more than one therapeutic antibody in the clinic. Our innovation is designed to address this need.

Platform & Technologies

We’re building new technologies and platforms to produce the next generation of therapeutic antibodies that are capable of targeting multiple molecules and pathways.